World's First AI Solution for Flagging PE Receives FDA Approval
By MedImaging International staff writers Posted on 01 Jun 2019 |
Image: The FDA has approved a new AI solution for finding and triaging PEs in CT scans (Photo courtesy of Aidoc).
An artificial intelligence (AI) solution for flagging pulmonary embolism (PE) has been granted clearance by the US FDA. The solution has been developed by Aidoc (Tel Aviv, Israel), a provider of AI solutions for radiologists, and works with radiologists to flag and triage PE cases in chest CTs.
Aidoc's solutions analyze medical images directly after the patient is scanned and notify the radiologists of cases with suspected findings to assist with prioritization of time-sensitive and potentially life-threatening cases. Aidoc cuts the time from scan to diagnosis for some patients from hours to less than five minutes, speeding up treatment and improving prognosis. Aidoc’s latest PE solution adds to its expanding suite of AI-based workflow orchestration solutions. PE diagnosis can be highly challenging due to its variable and non-specific presentation, making AI-driven workflow triage especially beneficial.
"What really excites us about this clearance is that it paves the way towards scalable product expansion," said Elad Walach, Aidoc co-founder and CEO. "We strive to provide our customers with comprehensive end-to-end solutions and have put a lot of effort in developing a scalable AI platform. It took us 18 months to get our first FDA clearance, 6 for the second one, and we have 8 more packages in active clinical trials, I'm excited about what will come next. I can only extend my utmost gratitude to the FDA for having open communication channels and working together with us on clearing many solutions in parallel."
Related Links:
Aidoc
Aidoc's solutions analyze medical images directly after the patient is scanned and notify the radiologists of cases with suspected findings to assist with prioritization of time-sensitive and potentially life-threatening cases. Aidoc cuts the time from scan to diagnosis for some patients from hours to less than five minutes, speeding up treatment and improving prognosis. Aidoc’s latest PE solution adds to its expanding suite of AI-based workflow orchestration solutions. PE diagnosis can be highly challenging due to its variable and non-specific presentation, making AI-driven workflow triage especially beneficial.
"What really excites us about this clearance is that it paves the way towards scalable product expansion," said Elad Walach, Aidoc co-founder and CEO. "We strive to provide our customers with comprehensive end-to-end solutions and have put a lot of effort in developing a scalable AI platform. It took us 18 months to get our first FDA clearance, 6 for the second one, and we have 8 more packages in active clinical trials, I'm excited about what will come next. I can only extend my utmost gratitude to the FDA for having open communication channels and working together with us on clearing many solutions in parallel."
Related Links:
Aidoc
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures